- Home
- / scPharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
scPharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$4.4
2024-10-29
Market Capitalization
$221.6 M
2024-10-29
Revenue
$36.3 M
FY, 2024
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 13.6M | 36.3M | |||||
| Cost of goods sold | 3.8M | 11.4M | |||||
| Gross profit | 25.0M | ||||||
| Gross profit margin, % | 68.7% | ||||||
| General and administrative expense | 13.7M | 8.3M | 11.8M | 9.8M | 20.6M | 53.4M | 77.6M |
| Operating expense total | 29.7M | 32.9M | 29.9M | 36.2M | 65.2M | 89.7M | |
| Depreciation and amortization | 38.0K | ||||||
| EBIT | (29.7M) | (32.9M) | (29.9M) | (25.8M) | (36.2M) | (55.4M) | (64.8M) |
| EBIT margin, % | -178.3% | ||||||
| Interest income | 1.7M | 1.7M | 315.0K | 49.0K | 1.2M | 5.1M | 3.4M |
| Interest expense | 8.1M | 7.6M | |||||
| Net Income | (29.4M) | (33.0M) | (32.2M) | (28.0M) | (36.8M) | (54.8M) | (85.1M) |
| EPS | (1.3) | (1.0) | (1.9) |